6300-95-4

Basic information

• Product Name: 6-phenyldihydropyrimidine-2,4(1H,3H)-dione
• Synonyms: 2,4(1H,3H)-Pyrimidinedione, dihydro-6-phenyl-; 6-Phenyldihydropyrimidine-2,4(1H,3H)-dione
• CAS NO: 6300-95-4
• Molecular Formula: C₁₀H₁₀N₂O₂
• Molecular Weight: 190.1986
• Mol File: 6300-95-4.mol
• Article Data: 6

Chemical Properties

• Density: 1.221g/cm³
• Refractive Index: 1.553
• CAS DataBase Reference: 6-phenyldihydropyrimidine-2,4(1H,3H)-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 6-phenyldihydropyrimidine-2,4(1H,3H)-dione(6300-95-4)
• EPA Substance Registry System: 6-phenyldihydropyrimidine-2,4(1H,3H)-dione(6300-95-4)

Safety Data

• Hazardous Substances Data: 6300-95-4(Hazardous Substances Data)

Upstream product

• 21428-07-9 β-phenyl-propionic acid β-ureide 
• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 57-13-6 urea 
• 621-82-9 Cinnamic acid 
• 140-10-3 (E)-3-phenylacrylic acid 
• 5962-06-1 trans-cinnamoylurea 
• 6335-76-8 3-amino-3-phenylpropionic acid ethyl ester 
• 112380-45-7 2-methylsulfanyl-6-phenyl-5,6-dihydro-3H-pyrimidin-4-one 
• 103-26-4 methyl cinnamate 
• 591-51-5 phenyllithium 
• 3646-50-2 3-Amino-3-phenylpropionic acid 
• 100-52-7 benzaldehyde 
• 471259-71-9 (RS)-3-amino-3-phenyl-propionic acid hydrochloride 
• 2033-24-1 cycl-isopropylidene malonate 

Downstream Products

• 13345-09-0 6-phenyluracil 
• 101012-73-1 4-(2,6-dioxo-hexahydro-pyrimidin-4-yl)-benzenesulfonyl chloride 
• 21428-07-9 β-phenyl-propionic acid β-ureide 
• 7614-93-9 1,3-diphenyl-1-butene 
• 621-82-9 Cinnamic acid 
• 3646-50-2 3-Amino-3-phenylpropionic acid 
• 84796-63-4 β-phenylalanine 
• 99056-54-9 4-(2,6-dioxo-hexahydro-pyrimidin-4-yl)-benzenesulfonic acid amide 
• 107626-81-3 4-(2,6-dioxo-hexahydro-pyrimidin-4-yl)-benzenesulfonic acid 
• 90946-83-1 5,6-dihydro-6-(4-nitrophenyl)pyrimidine-2,4(1H,3H)-dione 

Relevant articles and documents

-

-

DIHYDROURACIL COMPOUNDS AS ANTI-ICTOGENIC OR ANTI-EPILEPTOGENIC AGENTS

Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent or treat ictogenesis, epileptogenesis, or epileptogenesis-associated conditions. Methods for preparing the compounds of the invention are also described. Particularly preferred compounds of the invention include Formula 1 as described herein.

Synthesis and evaluation of anticonvulsant activities of some new arylhexahydropyrimidine-2,4-diones

In this study, some new 3-alkyl-6-arylhexahydropyrimidine-2,4-dione derivatives were synthesized as anticonvulsant agents. 6-Arylhexahydropyrimidine-2,4-diones which were used as starting materials in the synthesis of the compounds were prepared in acidic